Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.

Varga C, Comenzo RL.

Bone Marrow Transplant. 2018 Aug 8. doi: 10.1038/s41409-018-0284-4. [Epub ahead of print]

PMID:
30089901
2.

Sterile v aseptic non-touch technique for needle-less connector care on central venous access devices in a bone marrow transplant population: A comparative study.

Flynn JM, Keogh SJ, Gavin NC.

Eur J Oncol Nurs. 2015 Dec;19(6):694-700. doi: 10.1016/j.ejon.2015.05.003. Epub 2015 Jun 6.

PMID:
26059324
3.

Risk factors for depression in patients undergoing hematopoietic cell transplantation.

Artherholt SB, Hong F, Berry DL, Fann JR.

Biol Blood Marrow Transplant. 2014 Jul;20(7):946-50. doi: 10.1016/j.bbmt.2014.03.010. Epub 2014 Mar 18.

4.

Bone marrow mesenchymal stromal cells and olfactory ensheathing cells transplantation after spinal cord injury--a morphological and functional comparison in rats.

Torres-Espín A, Redondo-Castro E, Hernández J, Navarro X.

Eur J Neurosci. 2014 May;39(10):1704-17. doi: 10.1111/ejn.12542. Epub 2014 Mar 18.

PMID:
24635194
5.

Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Baker KS, Ness KK, Weisdorf D, Francisco L, Sun CL, Forman S, Bhatia S.

Leukemia. 2010 Dec;24(12):2039-47. doi: 10.1038/leu.2010.210. Epub 2010 Sep 23.

6.

Outcomes of touch therapies during bone marrow transplant.

Smith MC, Reeder F, Daniel L, Baramee J, Hagman J.

Altern Ther Health Med. 2003 Jan-Feb;9(1):40-9.

PMID:
12564350

Supplemental Content

Loading ...
Support Center